Revolution Medicines (RVMD) Cash & Equivalents (2019 - 2026)
Revolution Medicines (RVMD) posted Cash & Equivalents of $815.44 million for Q2 2026, up 102.6% from $402.44 million a year earlier and up 84.9% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines' Cash & Equivalents came in at $383.75 million, down 29.3% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 29.8% (FY2020 to FY2025).
- In prior years, Revolution Medicines' Cash & Equivalents was $543.06 million in FY2024 (-22.0%), $696.15 million in FY2023 (+331.3%), $161.41 million in FY2022 (+48.8%) and $108.5 million in FY2021 (+4.1%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents in data going back to Q1 2019.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 13.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2023, with growth of 337.4%; the weakest was Q1 2022, with a decline of 72.2%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $440.94 million (Q1 2026), $383.75 million (Q4 2025) and $217.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 815.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 815.44 Mn |
| Mar 31, 2026 | 440.94 Mn |
| Dec 31, 2025 | 383.75 Mn |
| Sep 30, 2025 | 217.44 Mn |
| Jun 30, 2025 | 402.44 Mn |
| Mar 31, 2025 | 333.55 Mn |
| Dec 31, 2024 | 543.06 Mn |
| Sep 30, 2024 | 201.26 Mn |
| Jun 30, 2024 | 275.71 Mn |
| Mar 31, 2024 | 288.43 Mn |
| Dec 31, 2023 | 696.15 Mn |
| Sep 30, 2023 | 358.40 Mn |
| Jun 30, 2023 | 380.33 Mn |
| Mar 31, 2023 | 427.22 Mn |
| Dec 31, 2022 | 161.41 Mn |
| Sep 30, 2022 | 178.94 Mn |
| Jun 30, 2022 | 105.78 Mn |
| Mar 31, 2022 | 97.67 Mn |
| Dec 31, 2021 | 108.50 Mn |
| Sep 30, 2021 | 129.15 Mn |
API Access
Revolution Medicines Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();